ClinicalTrials.govpublic full text
Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients
stomach cancer, stomach neoplasm, gastric cancer, gastroesophageal junction adenocarcinoma, ramucirumab, elderly patient, second line therapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 866248
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.